Muna Therapeutics

BiotechnologySeries ACopenhagen, Denmarkmunatherapeutics.com

Latest round

Series A

Last raised

Jul 2021

Total raised

$72M

Investors

8

About Muna Therapeutics

Based in Copenhagen, Denmark, and founded in 2020 by co-founders Bart De Strooper and Simon Glerup, Muna Therapeutics operates as a biopharmaceutical company. The company was founded by Professor Simon Glerup. Muna Therapeutics is a private biopharmaceutical company that discovers and develops therapies for neurodegenerative diseases including Alzheimer's, Frontotemporal Dementia, and Parkinson's. These disorders impact memory, movement, language, behavior, and personality resulting in the disability and death of millions of patients globally. The company focuses on science that identifies new medicines to preserve cognition and other brain functions and enhance resilience to neurodegenerative diseases.

Who invested in Muna Therapeutics

8 investors across 1 round

See all investors in Muna Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jul 9, 2021

    Amount

    $72M

    Investors

    Locked

Questions about Muna Therapeutics

Who invested in Muna Therapeutics?

Muna Therapeutics has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Muna Therapeutics raised?

Muna Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Muna Therapeutics last raise money?

Muna Therapeutics's most recent round on record is a Series A, in Jul 2021.

What does Muna Therapeutics do?

Based in Copenhagen, Denmark, and founded in 2020 by co-founders Bart De Strooper and Simon Glerup, Muna Therapeutics operates as a biopharmaceutical company.

Where is Muna Therapeutics headquartered?

Muna Therapeutics is headquartered in Copenhagen, Denmark.

Which VCs invest in companies like Muna Therapeutics?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Muna Therapeutics's stage. Their profiles are linked below.

Raising like Muna Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.